Last Updated: 24 January 2018
Jazz Pharmaceuticals, Inc. and its subsidiaries ("we", "us" and "our") recognise the importance of and are committed to respecting and protecting your privacy. This Privacy Statement applies to our collection and use of personal information through our websites or mobile applications (together, the "Site") and through our offline business-related interactions with you.
Please read this Privacy Statement carefully in order to understand how we process personal information. If you do not agree with our use of your personal information as described in this Privacy Statement, please do not use the Site or otherwise provide personal information to us.
Because of our commitment to the protection of your personal information, we evaluate our privacy policies and procedures to implement improvements and refinements from time to time. If we make material changes to this Privacy Statement, we will notify you by means of a prominent notice on this Site prior to the change becoming effective.
Personal information is information that identifies you as an individual or relates to an identifiable individual. We may collect and process the following personal information about you:
Our collection of your personal information is necessary for us to provide you with the requested service, including services available through the Site. As a result, we have a legitimate interest to collect your personal information, including to provide you with the requested service or to perform our obligations under our contractual relationship with you. If you choose not to provide personal information, we may not be able to provide you with the requested services.
We may also receive personal information about you from other sources, which could include commercially available sources, such as public databases and data aggregators to the extent permitted by applicable data protection laws.
In addition, we automatically collect basic technical information from all visitors to the Site. We collect technical information during your visit to the Site through our automatic data collection tools, which may include cookies and other commonly used technologies. These tools collect certain standard information that your browser sends to the Site such as your browser type and language, access times, and the address of the site from which you came to the Site. They may also collect information about your Internet Protocol (IP) address, or click stream data within the Site (i.e. the actions taken in connection with the Site). Please see “Cookies and other similar technologies” below for additional detail about the information we collect through cookies and other commonly used technologies.
Similarly, we may share your personal information as required or permitted by law to comply with a subpoena or similar legal process or government request, or when we believe in good faith that disclosure is legally required or otherwise necessary to protect our rights and property, or the rights, property or safety of others, including to advisers, law enforcement, judicial and regulatory authorities. We may also transfer your personal information to a third party in the event of any reorganization, merger, sale, joint venture, assignment, transfer or other disposition of all or any portion of our business, assets, or shares (including in connection with any bankruptcy or similar proceedings.)
The servers used in the operation of the Site automatically identify a computer by its IP address. If we, in good faith, determine that you have or are attempting to misuse or harm the Site, we may investigate and cooperate with appropriate law enforcement to protect our rights or property.
For our transfer of personal information from the EEA to any countries not recognized by the European Commission as providing an adequate level of data protection according to EEA standards, we have implemented adequate measures to protect the information, such as our certification to the EU-U.S. Privacy Shield Framework and the Swiss-U.S. Privacy Shield Framework for transfers to Jazz Pharmaceuticals U.S. and standard contractual clauses adopted by the European Commission where needed. If you are located in the EEA, you can request more information about these measures by contacting us at the address or email address in the “Contacting Information” section below.
EU-U.S. Privacy Shield [and Swiss-U.S. Privacy Shield]
Jazz Pharmaceuticals Inc. and its subsidiary Celator Pharmaceuticals Inc. (together "Jazz Pharmaceuticals U.S.") have self-certified to the EU-U.S. Privacy Shield Framework and the Swiss-U.S. Privacy Shield Framework (together the "Privacy Shield") as set forth by the U.S. Department of Commerce, and they adhere to the Privacy Shield Principles (the "Principles") regarding the processing of personal information transferred from organizations in the EU and Switzerland to Jazz Pharmaceuticals U.S. in the U.S. To learn more about the Privacy Shield program, and to view Jazz Pharmaceuticals U.S.'s certification, please visit http://www.privacyshield.gov.
The Jazz Pharmaceuticals U.S. certification covers both "personal information" which means any information from which an individual can be directly or indirectly identified, as well as "sensitive personal information" which means personal information revealing an individual's racial or ethnic origin, political opinions or membership of political parties or similar movements, religious or philosophical beliefs, membership of a professional or trade organization or union, physical or mental health, including any opinion thereof, sex life, and, where permitted by applicable law, criminal offences and alleged offences, criminal records or proceedings with regard to criminal or unlawful behavior. Where the individual is based in Switzerland, the definition of sensitive personal information also includes personal information revealing an individual's ideological views or activities, information on social security measures or administrative or criminal proceedings and sanctions, which are treated outside pending proceedings. The certification applies to personal information both in electronic or paper form, including personal information and sensitive personal information from agents, consultants, contractors, vendors, service providers, business associates, healthcare professionals, patients, clinical trial participants and others.
Under the Privacy Shield, Jazz Pharmaceuticals U.S. will offer an individual the opportunity to choose (opt-out) whether personal information about them will be disclosed to a third party or used for a purpose incompatible with the purpose for which it was originally collected or subsequently authorized by them, unless such choice is not required by law. For sensitive personal information, Jazz Pharmaceuticals U.S. will seek explicit (opt-in) consent before the sensitive personal information is disclosed to a third party or used for a purpose other than its original purpose or the purpose authorized subsequently by the individual.
Jazz Pharmaceuticals U.S. shall remain liable under the Principles if a third party agent uses or discloses personal information received from Jazz Pharmaceuticals U.S. in a manner inconsistent with the Principles, unless Jazz Pharmaceuticals U.S. proves that it is not responsible for the event giving rise to the damage.
With respect to personal information transferred or received pursuant to the Privacy Shield, Jazz Pharmaceuticals U.S. is subject to the investigatory and enforcement powers of the U.S. Federal Trade Commission. In certain instances, Jazz Pharmaceuticals U.S. may be required to disclose personal information in response to lawful requests by public authorities, including to meet national security or law enforcement requirements.
In compliance with the Privacy Shield Principles, Jazz Pharmaceuticals U.S. commits to resolve complaints about our collection or use of personal information received pursuant to the Privacy Shield. EU and Swiss individuals with inquiries or complaints regarding our Privacy Shield policy should first contact the Jazz Pharmaceuticals Group Privacy Office at email@example.com or at the address or telephone number listed below in “Contacting Us.” Where a complaint relates to personal information transferred or received pursuant to the Privacy Shield, Jazz Pharmaceuticals U.S. will respond within 45 days of receiving any such complaints. Jazz Pharmaceuticals U.S. has further committed to cooperate with the panel established by the EU data protection authorities (DPAs) and the Swiss Federal Data Protection and Information Commissioner (FDPIC) with respect to unresolved Privacy Shield complaints concerning data transferred from the EU and Switzerland. If you are unsatisfied with the way Jazz Pharmaceuticals U.S. has responded to any such complaints or concerns about the handling of personal information about you in the context of the Privacy Shield (if applicable), you may contact your Data Protection Authority. Under certain circumstances, an individual may choose to invoke binding arbitration to resolve any Privacy Shield disputes that have not been resolved by other means.
We may retain your personal information for as long as your account is active or as needed for the specific business purpose for which it was collected. In some cases, we may be required to retain information to comply with laws or regulations or other legal obligations, resolve disputes and enforce our agreements.
We use the following session and persistent cookies on the Site:
We may use Adobe Flash technology (including Flash Local Shared Objects ("Flash LSOs")) and other similar technologies to, among other things, collect and store information about your use of the Site. If you do not want Flash LSOs stored on your computer, you can adjust the settings of your Flash player to block Flash LSO storage using the tools contained in the Website Storage Settings Panel. You can also go to the Global Storage Settings Panel and follow the instructions (which may explain, for example, how to delete existing Flash LSOs (referred to as "information", how to prevent Flash LSOs from being placed on your computer without your being asked, and how to block Flash LSOs that are not being delivered by the operator of the page you are on at the time). Please note that setting the Flash Player to restrict or limit acceptance of Flash LSOs may reduce or impede the functionality of some Flash applications.
In addition to cookies, tracking Gifs may be set by us or third parties in respect of your use of the Site. Tracking Gifs are small image files within the content of the Site or the body of our emails/newsletters so we or third parties can understand, for example, which emails have been opened by recipients. This allows us to gauge the effectiveness of certain communications and the effectiveness of our marketing campaigns.
If you would like to opt-out of tracking for advertising purposes, you may do so by following: (i) http://preferences-mgr.truste.com/; (ii) the Network Advertising Initiative at: http://www.networkadvertising.org/choices; or (iii) the European Interactive Digital Advertising Alliance at: http://youronlinechoices.eu/. For more information on how to disable tracking for certain web browsers and mobile devices, visit http://allaboutdnt.com/.
If you wish to stop receiving marketing or market research communications from us, you can contact us as described below to let us know what types of communications you wish to stop receiving.
Address: 3170 Porter Drive, Palo Alto, CA 94303, U.S.
Tel.: (650) 496-3777
For purposes of European data protection laws, Jazz Pharmaceuticals, Inc. is the data controller: i.e., the company responsible for controlling the processing of personal information covered by this Privacy Statement. Jazz’s Data Protection Officer can be reached using the contact information provided above.